Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Mitomycin C and Capecitabine Combination (MiXe) in Heavily Pretreated Metastatic Breast Cancer Patients. A Dose-finding Study

ROBERTO MAISANO, NICOLA CARISTI, MARZIA MARE, ANTONINO MAFODDA, RITA CARBONI, ERIKA MONTALTO, MONICA IORFIDA and MARIO NARDI
Anticancer Research November 2005, 25 (6C) 4513-4517;
ROBERTO MAISANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: maisano{at}supereva.it
NICOLA CARISTI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARZIA MARE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTONINO MAFODDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RITA CARBONI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERIKA MONTALTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MONICA IORFIDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIO NARDI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 6C 4513-4517
PMID 
16334135

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 25, 2005
  • Accepted July 4, 2005
  • Published online November 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ROBERTO MAISANO1,
  2. NICOLA CARISTI2,
  3. MARZIA MARE3,
  4. ANTONINO MAFODDA2,
  5. RITA CARBONI1,
  6. ERIKA MONTALTO2,
  7. MONICA IORFIDA2 and
  8. MARIO NARDI1
  1. 1Unità Operativa di Oncologia Medica, A.O. “Bianchi-Melacrino-Morelli” Reggio Calabria
  2. 2Unità Operativa di Oncologia Medica, A.O.U. “G. Martino” Policlinico Messina
  3. 3Divisione di Oncologia, Istituto Oncologico del Mediterraneo Viagrande Catania, Italy
  1. Correspondence to: Maisano Roberto, MD, Via Comunale Sperone Fortuna Residence, 98158 Messina Italy. Fax: +390965397106, e-mail: maisano{at}supereva.it

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 6C
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mitomycin C and Capecitabine Combination (MiXe) in Heavily Pretreated Metastatic Breast Cancer Patients. A Dose-finding Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Mitomycin C and Capecitabine Combination (MiXe) in Heavily Pretreated Metastatic Breast Cancer Patients. A Dose-finding Study
ROBERTO MAISANO, NICOLA CARISTI, MARZIA MARE, ANTONINO MAFODDA, RITA CARBONI, ERIKA MONTALTO, MONICA IORFIDA, MARIO NARDI
Anticancer Research Nov 2005, 25 (6C) 4513-4517;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Mitomycin C and Capecitabine Combination (MiXe) in Heavily Pretreated Metastatic Breast Cancer Patients. A Dose-finding Study
ROBERTO MAISANO, NICOLA CARISTI, MARZIA MARE, ANTONINO MAFODDA, RITA CARBONI, ERIKA MONTALTO, MONICA IORFIDA, MARIO NARDI
Anticancer Research Nov 2005, 25 (6C) 4513-4517;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with Anthracycline
  • Google Scholar

More in this TOC Section

  • Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
  • Unfavorable Outcomes of T3N0 Remnant Gastric Cancer After Distal Gastrectomy
  • Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire